Suppr超能文献

散瞳筛查早产儿视网膜病变后的全身不良事件。

Systemic adverse events after screening of retinopathy of prematurity with mydriatic.

机构信息

Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan.

Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.

出版信息

PLoS One. 2021 Sep 9;16(9):e0256878. doi: 10.1371/journal.pone.0256878. eCollection 2021.

Abstract

PURPOSE

To evaluate systemic adverse events after screening for retinopathy of prematurity (ROP) performed with mydriatic.

METHODS

This was a retrospective case series study. Medical records of consecutive patients who underwent screening for ROP with 0.5% phenylephrine and 0.5% tropicamide eyedrops were retrospectively reviewed. The score of abdominal distention (0-5), volume of milk sucked and volume of stool, along with systemic details (pulse and respiration rates, blood pressure and number of periods of apnea) were collected at 1 week and 1 day before ROP examination, and at 1 day after examination. Results were compared between the days before and after examination. Correlation between body weight at the time of examination and the score of abdominal distention was examined. The numbers of infants with abdominal and/or systemic adverse events were compared between pre- and post-examination periods.

RESULTS

Eighty-six infants met the inclusion criteria. The score of abdominal distention increased from 2.0 at 1 day before examination to 2.3 at 1 day after examination (p = 0.005), and the number of infants who had worsened abdominal distension increased after examination (p = 0.01). Infants with lower body weight had a higher score of abdominal distention (p < 0.0001, r = -0.57). The number of infants with reduced milk consumption increased after examination (p = 0.0001), as did the number of infants with decreased pulse rate (p = 0.0008).

CONCLUSIONS

Screening for ROP with mydriatic may have adverse effects on systemic conditions. Infants should be carefully monitored after ROP screening with mydriatic.

摘要

目的

评估使用散瞳剂进行早产儿视网膜病变(ROP)筛查后的全身不良事件。

方法

这是一项回顾性病例系列研究。回顾性分析了连续接受 0.5%苯肾上腺素和 0.5%托吡卡胺滴眼剂筛查 ROP 的患者的病历。在 ROP 检查前 1 周和 1 天以及检查后 1 天,收集腹胀评分(0-5)、吸吮奶量和粪便量以及全身详细情况(脉搏和呼吸频率、血压和呼吸暂停次数)。比较检查前后的结果。检查时体重与腹胀评分之间的相关性进行了检验。比较检查前后时期的腹部和/或全身不良事件的婴儿数量。

结果

86 名婴儿符合纳入标准。腹胀评分从检查前 1 天的 2.0 分增加到检查后 1 天的 2.3 分(p = 0.005),检查后腹胀加重的婴儿数量增加(p = 0.01)。体重较低的婴儿腹胀评分较高(p < 0.0001,r = -0.57)。检查后吸吮奶量减少的婴儿数量增加(p = 0.0001),脉搏率降低的婴儿数量也增加(p = 0.0008)。

结论

使用散瞳剂筛查 ROP 可能对全身状况产生不良影响。使用散瞳剂筛查 ROP 后,应密切监测婴儿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e7/8428556/28741b30778e/pone.0256878.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验